GlassScriptPhysician profile
Timothy John Morley
NPI 1174681837
$1,569.96
in general payments reported to CMS, 2019-2025
10 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $446 · 2023: $676 · 2024: $297 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,112 · Education: $11.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,111.83 |
| Education | $11.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $855.82 | 2022-2025 | Xifaxan, Trulance |
| Lilly USA, LLC | $185.15 | 2023-2024 | Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $152.94 | 2022-2023 | Nucala |
| Integra Lifesciences Corporation | $133.77 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Becton, Dickinson and Company | $81.43 | 2023 | Arista Ah Flexitip |
| Stryker Corporation | $58.37 | 2025 | Scopis Ent |
| Merck Sharp & Dohme LLC | $43.74 | 2022-2023 | Dificid |
| Abbvie INC. | $21.76 | 2025 | |
| Atos Medical INC | $18.61 | 2025 | Provox Life Home Hme |
| Bausch Health US, LLC | $18.37 | 2023 | Wellbutrin, Aplenzin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Morley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.